Guidance for Safety and Dosing of Medicines in Patients With Cirrhosis Is Available

Guidance for Safety and Dosing of Medicines in Patients With Cirrhosis Is Available

Bibliographic Details
Main Authors:	Rianne A. Weersink, Joost P.H. Drenth, Nicole G.M. Hunfeld, Sander D. Borgsteede
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2019-09-01
Series:	Hepatology Communications
Online Access:	https://doi.org/10.1002/hep4.1399

Similar Items

Why zolpidem increases the risk of falls and fractures in patients with cirrhosis
by: Rianne Antoinet Weersink, et al.
Published: (2022-12-01)

Collaboration Is Needed to Translate Pharmacology Data Into Better Health Outcomes in Chronic Liver Disease
by: Rianne A. Weersink, et al.
Published: (2021-04-01)

Improving Medication‐Related Outcomes in Chronic Liver Disease
by: Kelly L. Hayward, et al.
Published: (2020-11-01)

Aldosterone Antagonist Dosing and the Risk of Hyponatremia in Patients With Cirrhosis and Ascites
by: A.S. Vogel, et al.
Published: (2023-01-01)

Changing Prevalence of Medication Use in People with Cirrhosis: A Retrospective Cohort Study Using Pharmaceutical Benefits Scheme Data
by: Kelly L. Hayward, et al.
Published: (2023-10-01)

Short‐Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis
by: Mitchell R. McGill, et al.
Published: (2022-02-01)

Efficacy and Safety of Ascites Treatment in Liver Cirrhosis
by: G. A. Ignatenko, et al.
Published: (2022-07-01)

Efficacy and Safety of Emricasan in Liver Cirrhosis and/or Fibrosis
by: Li-ya Mu, et al.
Published: (2021-06-01)

Immunogenicity of COVID-19 vaccines in patients with cirrhosis: Expected advantage for additional dose of vaccine
by: Hinpetch Daungsupawong, et al.
Published: (2024-12-01)

Safety assessment of medicines available in the ‘Brazilian list of essential medicines’ in the older persons according to the Beers Criteria
by: Francelle Adorno Sôffa Guimarães Monteiro, et al.
Published: (2023-06-01)

Rapid onset of anaemia in a patient with alcoholic cirrhosis: The clue might be in the smear
by: Sander De Bruyne, et al.
Published: (2021-11-01)

A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia
by: Coppola, Danielle, et al.
Published: (2012)

Cryptococcemia in an HIV-negative patient with decompensated liver cirrhosis
by: Manasa Kandula, et al.
Published: (2016-12-01)

Gastroparesis in patients with inactive Crohn's disease: a case series
by: Oyen Wim JG, et al.
Published: (2007-03-01)

COVID-19 and dental sleep medicine: risks, precautions and patient guidance
by: Thays Crosara Abrahão Cunha, et al.
Published: (2020-07-01)

Nanotechnology safety and health : research and guidance /
by: Jenkins, Elizabeth F.
Published: (2011)

Availability and affordability of medicines for children
by: Irina Kazaryan, et al.
Published: (2015-12-01)

Safety, risk stratification, and cost of ERCP in patients with cirrhosis: a prospective controlled study
by: Ahmed Attia
Published: (2024-01-01)

Real-Life Experience in the Efficacy and Safety of COVID-19 Vaccination in Patients with Advanced Cirrhosis
by: Amr Shaaban Hanafy, et al.
Published: (2023-12-01)

Guidance on the use of the benchmark dose approach in risk assessment
by: EFSA Scientific Committee, et al.
Published: (2022-10-01)

A Single‐Center Experience on Outcomes of Complementary and Alternative Medicine Use Among Patients With Cirrhosis
by: Cyriac Abby Philips, et al.
Published: (2019-07-01)

Continuous effectiveness and safety after a hospital‐wide switch to adalimumab biosimilar: An observational study in rheumatoid arthritis patients
by: Rianne Brouwer, et al.
Published: (2022-12-01)

Aspirations, apprehensions and the availability of career guidance among dental interns in Kerala, India
by: P S Sajitha, et al.
Published: (2023-01-01)

Hepatoprotective Effects of Chinese Medicine Herbs Decoction on Liver Cirrhosis in Rats
by: Mat-Rahim, N.A., et al.
Published: (2017)

Lethargy in a patient with cirrhosis.
by: Chuah, S.Y., et al.
Published: (1997)

PNEUMONIA IN PATIENTS WITH LIVER CIRRHOSIS
by: R. V. Kazakova
Published: (2013-04-01)

Malnutrition in Patients with Liver Cirrhosis
by: Julia Traub, et al.
Published: (2021-02-01)

Burden of Cirrhosis on Patients and Caregivers
by: Michael L. Volk
Published: (2020-08-01)

Metronidazole-induced encephalopathy in a patient with cirrhosis
by: Xinyu Ji, MD, CM, et al.
Published: (2024-01-01)

EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment
by: Amy Hunter, et al.
Published: (2018-09-01)

Portal Vein Thrombosis in Patients with Liver Cirrhosis: What Went Wrong?
by: Georgescu D, et al.
Published: (2023-08-01)

Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries
by: Alexandra Cameron, et al.

Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
by: Yi-Te Lee, et al.
Published: (2023-04-01)

Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis
by: Patrick Marquardt, et al.
Published: (2021-09-01)

What guidance exists to support patient partner compensation practices? A scoping review of available policies and guidelines
by: Grace Fox, et al.
Published: (2024-02-01)

Health and safety in construction : guidance for construction professionals /
by: 238611 Barber, John
Published: (2002)

Guidance on the assessment of the safety of feed additives for the users
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2023-12-01)

SMART PHOTONIC GUIDANCE SYSTEM FOR ROAD SAFETY
by: Dariusz LITWIN, et al.
Published: (2020-12-01)

Guidance for the harmonisation and improvement of economic evaluations of personalised medicine
by: Vellekoop, H, et al.
Published: (2021)

COVID-19 Vaccination in Liver Cirrhosis: Safety and Immune and Clinical Responses
by: Inês Canha, et al.
Published: (2023-11-01)